Cargando…
Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma
Ovarian cancer is the seventh most common type of cancer and the eighth most common cause of cancer-associated mortality among women. A number of studies have hypothesized that the expression status of certain genes may be used to predict prognosis in ovarian cancer. In the present study, the RNA ex...
Autores principales: | Zhang, Jue, Xu, Meng, Gao, Han, Guo, Jin-Chen, Guo, Yu-Lin, Zou, Miao, Wu, Xu-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795895/ https://www.ncbi.nlm.nih.gov/pubmed/29456732 http://dx.doi.org/10.3892/ol.2018.7778 |
Ejemplares similares
-
A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma
por: Guo, Wenna, et al.
Publicado: (2018) -
Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma
por: Zhu, Yu-Ting, et al.
Publicado: (2023) -
A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma
por: Yu, Zhixiang, et al.
Publicado: (2021) -
Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma
por: Li, Li, et al.
Publicado: (2023) -
Gastric metastasis of ovarian serous cystadenocarcinoma
por: Yang, Shiqiang
Publicado: (2018)